Navigation Links
ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Date:4/23/2009

For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) the potency, safety and tolerability profile of ANA598, which may not be duplicated in future cohorts at higher doses or future clinical studies of longer duration; (ii) the belief that ANA598 is a leading non-nucleoside polymerase inhibitor in development for the treatment of HCV; (iii) the expectation that ANA598 will be active in long-term studies in combination with pegylated interferon and ribavirin and the ability to dose ANA598 for up to 48 weeks in future combination studies; (iv) the ability of Anadys to transition into Phase II studies of ANA598 during 2009; and (v) expectations regarding the evolution of the market for HCV therapies. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies (including those described in this press release) may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues, will have favorable results in future clinical trials, will maintain fast track designation or will receive regulatory approval. In addition, Anadys' results may be affected by risks related to competition from other biotechnology and pharmaceutical companies
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
2. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
3. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
6. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
9. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
10. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
11. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that on ... (the "Notice") executed by the Marc S. Hermelin Revocable ... that the Board of Directors of the Company (the ... written consent relating to the proposed appointment of John ... Ronald J. Kanterman,s departure (the "Director Appointment"). ,, As ...
(Date:12/15/2009)... Ever wonder what something looks like up ... of the Personal Scanning Electron Microscope (PSEM), kicked off ... send in samples to be scanned by one of ... scan range of 100nm to 5mm and an imaging ... into focus. In addition, ASPEX will not only scan ...
(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 1Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 2Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 3Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 4Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 5Health Plans Reduce Administrative Expenses with HEALTHsuite 28R 29 from RAM Technologies Inc 57678 1Health Plans Reduce Administrative Expenses with HEALTHsuite 28R 29 from RAM Technologies Inc 57678 2With Alcohol Starting Young May Lead to Dependency 57676 1With Alcohol Starting Young May Lead to Dependency 57676 2
... studies presented at the American Urological Association,s (AUA) 104th ... prescribed to lower cholesterol--may benefit men with prostate cancer, ... key research studies highlighting these benefits will be presented ... Monday, April 27 from 9 to 10:30 a.m. ...
... April 27 As body mass increases, ... (UTI), according to Baltimore researchers. A new study, presented ... Urological Association (AUA), assesses and stratifies this risk.Researchers evaluated ... period (from 2002 through 2006) to identify whether obesity ...
Other Medicine Technology:New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health 2Obesity Associated With Higher Risk for Urinary Tract Infections 2
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... needed for protection, CDC says, , , TUESDAY, Dec. 15 ... swine flu vaccine have been recalled by manufacturer Sanofi ... health officials said Tuesday. , According to the U.S. ... testing of the vaccine for children aged 6 months ... lower than required potency levels. "This means that doses ...
(Date:12/15/2009)... Dec. 15 4R Systems, Inc., a ... solutions which help retailers significantly increase profits by ... announced today that The Vitamin Shoppe has been ... "4R,s store and DC inventory solutions have helped ... and in-stocks over the last two years," said ...
(Date:12/15/2009)... -- North American application activity for individually underwritten ... to the MIB Life Index(SM) . ... past three months have lifted year-to-date (YTD) figures ... flat at November,s close, -0.1%. "It is ... benefits available from life insurance," says Stacy Gill, ...
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2
... 25 years of industry experience, COPPELL, Texas, ... a leading developer and provider of dietary,supplements and ... Marika,Berkley as the company,s vice president of global ... pleased to announce Marika,s addition to our,management team," ...
... 2008) -- An enzyme released by mast cells in the ... of airways that is a hallmark of asthma -- pointing ... , Reporting in the online edition of Proceedings of the ... College explains that during an immune response, mast cells release ...
... shows early promise for diagnosing, treating tumors , , ... not a particular cancer will be aggressive allows doctors ... found class of molecules called microRNAs may help doctors ... on a particular microRNA, designated miR-21, that may predict ...
... was also lower than researchers anticipated , , TUESDAY, Jan. ... the real-life effectiveness of two different drug-coated stents, Danish ... and a lower rate of problems than had been ... people who had these flexible tubes implanted to help ...
... Just in time for the Superbowl,NaturalNews.com has launched ... Blueberry battling it out against Junk Foods,running back ... the,performance-enhancing properties of superfoods in a fun, entertaining ... , The Super Foods team features Tom ...
... Ga., Jan. 29 Immucor, Inc. (Nasdaq:,BLUD), a ... blood transfusion industry, announced today that Ronny B. ... effective February 1, 2008. Mr.,Lancaster currently serves as ... Inc., and previously served as Senior Vice,President and ...
Other Medicine News:Health News:Mannatech Names New VP of Regulatory Affairs, Quality Assurance 2Health News:Mannatech Names New VP of Regulatory Affairs, Quality Assurance 3Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 2Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 3Health News:MicroRNAs May Predict Colon Cancer Prognosis 2Health News:MicroRNAs May Predict Colon Cancer Prognosis 3Health News:Study Finds Both Coated Stents Perform the Same 2Health News:Study Finds Both Coated Stents Perform the Same 3Health News:Super Food Bowl Animation From NaturalNews.com Teaches Kids to Avoid Junk Foods, Pursue Natural Nutrition 2Health News:Immucor, Inc. Adds Director to Board 2
... and economic issues of cerclage wiring, the ... maximize tension control while minimizing invasion of ... instrumentation with a simple technique. , ... for general orthopaedic trauma surgery involving: Olecranon ...
OmniAccess&trade Hip Retractor System sets a new standard in hip exposure. It provides constant, absolute exposure of the acetabulum during total hip arthroplasty and revision procedures....
... Many of DePuy's aggressive innovations have ... yet to be equalled. The AML ... stem to efficiently address and effectively meet ... hip arthroplasty. With greater than 15 ...
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Medicine Products: